Trial record 7 of 1888 for:
Acetaminophen
Clinical, Pharmacological and Molecular Effects of IV and Oral Acetaminophen in Adults With aSAH (aSAH)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02549716 |
Recruitment Status :
Terminated
(Funding was stopped)
First Posted : September 15, 2015
Results First Posted : April 10, 2019
Last Update Posted : April 10, 2019
|
Sponsor:
Milton S. Hershey Medical Center
Information provided by (Responsible Party):
Sprague W Hazard III, Milton S. Hershey Medical Center
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Triple (Participant, Care Provider, Investigator); Primary Purpose: Treatment |
Conditions |
Subarachnoid Hemorrhage Stroke |
Interventions |
Drug: IV acetaminophen Drug: Oral acetaminophen Drug: Oral placebo Drug: IV placebo |
Enrollment | 3 |
Participant Flow
Recruitment Details | |
Pre-assignment Details |
Baseline Characteristics
Outcome Measures
Adverse Events
Limitations and Caveats
Study was terminated early
More Information
Results Point of Contact
Name/Title: | Sprague W. Hazard III, M.D. |
Organization: | Milton S. Hershey Medical Center |
Phone: | 717-531-0003 ext 311253 |
EMail: | shazard@pennstatehealth.psu.edu |
Responsible Party: | Sprague W Hazard III, Milton S. Hershey Medical Center |
ClinicalTrials.gov Identifier: | NCT02549716 History of Changes |
Other Study ID Numbers: |
IRBSTUDY00002767 |
First Submitted: | July 1, 2015 |
First Posted: | September 15, 2015 |
Results First Submitted: | February 28, 2019 |
Results First Posted: | April 10, 2019 |
Last Update Posted: | April 10, 2019 |